Home » Newsletters » BioWorld

BioWorld

Feb. 3, 1992

View Archived Issues

ANALYST LOWERS AMGEN RATING

GENSIA TO SPLIT STOCK 3 for 2

BELGIUM APPROVES BTGC GROWTH HORMONE

GENELABS DEAL FOR ANTI-CANCER DRUG

APPOINTMENTS AND ADVANCEMENTS

SOMATIX LICENSES MYOBLAST GENE THERAPY

FEDERAL BIOTECH PRIORITIES FOR 21st CENTURY

JUDGE REFUSES TO SET ASIDE XOMA RULING

$687 MILLION IN OFFERINGS FOR MONTH

FDA PANEL TURNS DOWN U.S. BIO'S ETHYOL